Company news

Modalis Therapeutics Corporation news in 2026

Modalis Therapeutics Corporation's news releases, calls and decks from 2026, newest first.

View company

Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy

September 10, 2026

(Correction) Regarding Corrections to the "Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]"

August 13, 2026

Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]

August 10, 2026

Business Plans and Matters Related to Growth Potential

July 14, 2026

Decks in 2026